Healthcare • Medical Devices
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if QTRX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
13 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: buy 62 days ago
Red flags: 9
132 filers reported a long position in QTRX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $15.7M | 3.6M | +10.9% |
| Blue Water Life Science Advisors, LP | $15M | 3.5M | +62.2% |
| First Eagle Investment Management, LLC | $11.9M | 2.8M | +111.8% |
| Portolan Capital Management, LLC | $8.2M | 1.9M | -35.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.8M | 1.8M | +0.9% |
| Lionhunter Capital Management, LLC | $6.5M | 1.5M | — |
| AQR CAPITAL MANAGEMENT LLC | $5.8M | 1.3M | +1,496.3% |
| GEODE CAPITAL MANAGEMENT, LLC | $4.9M | 1.1M | +13.7% |
| AMERIPRISE FINANCIAL INC | $4.3M | 987.4K | -72.1% |
| MARSHALL WACE, LLP | $4.2M | 973.9K | +56.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.